Delivery Order SPE2DR25D2013-SPE2DR26F5QTL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with a ceiling value of $1,904.63 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens with a ceiling value of $48,874.25. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens at a ceiling value of $1,053.68. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a competitive award under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,738.69 and an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pens with a ceiling value of $1,317.10. This non-set-aside, firm fixed-price delivery order is scheduled for completion by November 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product delivery supports the military and federal healthcare supply chain, consistent with the...
- The Defense Logistics Agency awarded a delivery order valued at $11,592.97 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the place of performance for this transaction. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $19,862.57 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical distributor for federal military and healthcare systems. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,902.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pens with a completion date of December 2, 2025. This competitively awarded contract, which carries no set-aside designation, is for pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $1,632.54 with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens valued at $7,129.50. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and no set-aside designation was used in the award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a competitively awarded contract, this order...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QTLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens with a ceiling value of $6,741.93. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete openly for federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The Mounjaro supply represents one of numerous pharmaceutical products delivered through this prime contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains for use by the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 12/10/25 |